Concept Medical, Inc. — SEC Form D Filing

Concept Medical, Inc. filed an SEC Form D on April 24, 2026, reporting $60.04M raised in Health Care.

Form D filing details

Filing
SEC Form D
Filing date
April 24, 2026
Amount reported
$60.04M
Round stage
Series A
Industry
Health Care
Website
https://www.conceptmedical.com/

What the company does

Securities: Equity, Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Coronary and peripheral artery diseases require effective treatment options.

Solution

Concept Medical develops Drug Eluting Stents and Drug Coated Balloons using proprietary technology for treating coronary and peripheral artery diseases.

Verdict

Investors backed Concept Medical because they recognized a pressing need for effective treatments in a well-defined healthcare sector, betting on the novelty of their proprietary drug delivery technology. This cleared because the pain point of cardiovascular diseases was urgent and legitimate, not because there was strong clarity on target buyers or budget owners. The limited upside lies in the highly competitive medical device landscape, with existing players already entrenched and a scarcity of defined differentiators.

Source: SEC EDGAR Form D filing